- Home
- TCRT vs ISPC Comparison
TCRT vs ISPC Comparison
Compare TCRT & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRT
- ISPC
- Stock Information
- Founded
- TCRT 1998
- ISPC 2009
- Country
- TCRT United States
- ISPC United States
- Employees
- TCRT N/A
- ISPC N/A
- Industry
- TCRT Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- TCRT Health Care
- ISPC Health Care
- Exchange
- TCRT Nasdaq
- ISPC Nasdaq
- Market Cap
- TCRT 3.9M
- ISPC 4.6M
- IPO Year
- TCRT N/A
- ISPC 2021
- Fundamental
- Price
- TCRT $2.33
- ISPC $1.79
- Analyst Decision
- TCRT
- ISPC
- Analyst Count
- TCRT 0
- ISPC 0
- Target Price
- TCRT N/A
- ISPC N/A
- AVG Volume (30 Days)
- TCRT 340.1K
- ISPC 16.2M
- Earning Date
- TCRT 08-14-2025
- ISPC 11-06-2025
- Dividend Yield
- TCRT N/A
- ISPC N/A
- EPS Growth
- TCRT N/A
- ISPC N/A
- EPS
- TCRT N/A
- ISPC N/A
- Revenue
- TCRT $6,000.00
- ISPC $5,908,088.00
- Revenue This Year
- TCRT $5,680,500.00
- ISPC $35.93
- Revenue Next Year
- TCRT N/A
- ISPC N/A
- P/E Ratio
- TCRT N/A
- ISPC N/A
- Revenue Growth
- TCRT N/A
- ISPC N/A
- 52 Week Low
- TCRT $1.31
- ISPC $0.64
- 52 Week High
- TCRT $6.20
- ISPC $8.30
- Technical
- Relative Strength Index (RSI)
- TCRT 48.79
- ISPC 64.06
- Support Level
- TCRT $2.15
- ISPC $1.05
- Resistance Level
- TCRT $2.39
- ISPC $3.18
- Average True Range (ATR)
- TCRT 0.22
- ISPC 0.39
- MACD
- TCRT 0.08
- ISPC 0.11
- Stochastic Oscillator
- TCRT 81.97
- ISPC 46.46
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.